---
title: "LifeVantage Q2 revenue falls 27.8%, misses estimates"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/274867530.md"
datetime: "2026-02-04T21:11:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274867530.md)
  - [en](https://longbridge.com/en/news/274867530.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274867530.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/274867530.md) | [English](https://longbridge.com/en/news/274867530.md)


# LifeVantage Q2 revenue falls 27.8%, misses estimates

)

Overview

-   Health and wellness firm’s Q2 revenue fell 27.8%, missing analyst expectations
-   Adjusted EPS for Q2 was $0.15, down from $0.22 a year ago
-   Company announced a new $60 mln share repurchase program

Outlook

-   LifeVantage expects fiscal 2026 revenue between $185 mln and $200 mln
-   Company forecasts adjusted EBITDA of $15 mln to $19 mln for fiscal 2026
-   LifeVantage projects adjusted EPS of $0.60 to $0.80 for fiscal 2026

Result Drivers

-   GLP-1 SYSTEM CHALLENGES - Revenue decline driven by decreased sales of MindBody GLP-1 System as company cycled its launch
-   LOVEBIOME OFFSET - Sales of LoveBiome product line partially offset revenue decline, acquired in October 2025

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Miss $48.93 $54.39

Revenue mln mln (3

Analysts

)

### Q2 EPS $0.02

Q2 Net $276,000

Income

Q2 Gross $36.21

Profit mln

### Q2 $35.72

Operatin mln

g

Expenses

### Q2 $487,000

Operatin

g Income

### Q2 $473,000

Pretax

Profit

Analyst Coverage

-   The current average analyst rating on the shares is “buy” and the breakdown of recommendations is 2 “strong buy” or “buy”, no “hold” and no “sell” or “strong sell”
-   The average consensus recommendation for the pharmaceuticals peer group is “buy”
-   Wall Street’s median 12-month price target for LifeVantage Corp is $14.50, about 170.5% above its February 3 closing price of $5.36
-   The stock recently traded at 5 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release: For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact . (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

### 相關股票

- [Lifevantage (LFVN.US)](https://longbridge.com/zh-HK/quote/LFVN.US.md)

## 相關資訊與研究

- [LifeVantage meldet Umsatz im zweiten Quartal 2026 von 48,93 Mio. USD, Rückgang um 27,8 Prozent](https://longbridge.com/zh-HK/news/274865595.md)
- [LifeVantage Names Mike Edwards Chief Technology Officer](https://longbridge.com/zh-HK/news/271837367.md)
- [LifeVantage Corporation to Announce Second Quarter Fiscal Year 2026 Results](https://longbridge.com/zh-HK/news/273279662.md)
- [Board Member Of Lifevantage Makes $152K Buy](https://longbridge.com/zh-HK/news/277643544.md)
- [LifeVantage Director Darwin Lewis Reports Acquisition of Common Shares](https://longbridge.com/zh-HK/news/275661155.md)